by Wageningen University Single-molecule scale Alzheimer’s peptide aggregates. Credit: Wageningen University & Research Understanding how certain chemicals interact with molecular processes in our body is key to developing effective medications. This certainly holds true for complex neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, for which no effective treatment is available as of yet. Scientists from Wageningen University...
By RACHAEL BUNYAN FOR MAIL ONLINE A new antibody treatment with the potential to give people instant immunity after being exposed to Covid-19 and prevent illness is being trialled by scientists in the UK. The drug would offer immediate and long-term protection to patients when it would be too late to offer a vaccine, potentially saving thousands...
ELIFE A drug that boosts the removal of cellular debris in immune cells may increase the protective effects of vaccines in older adults, a study published today in eLife shows. The results may lead to new approaches to protect older individuals from viruses such as the one causing the current COVID-19 pandemic and influenza. “Older adults are...
2020POSTED BY ELLEN GOLDBAUM-BUFFALO “During the period just after diagnosis, called partial remission or the honeymoon period, patients are still able to make some insulin on their own,” says Teresa Quattrin. “That is the period we have targeted with this study of golimumab.” (Credit: Getty Images)SHARE THIS ARTICLE Facebook Twitter Email You are free to share this...
Drug to reduce bleeding could treat COVID-19 A recent study has shown that aprotinin, a drug that reduces the risk of bleeding during surgery, can stop the novel coronavirus from entering host cells. The drug could serve to prevent severe cases of COVID-19, the authors say. Share on PinterestImage credit: MirageC / Getty Images. With...
by Linda A. Johnson In this Feb. 12, 2019 photo, Meghan Waldron walks down the street in Boston. Waldron is a student at Emerson College with progeria, one of the world’s rarest diseases. The first treatment has been approved for progeria, Friday, Nov. 20, 2020. The U.S. Food and Drug Administration on Friday approved Zokinvy...
A team of researchers led by biomedical scientist Declan McCole at the University of California, Riverside, has found that the drug tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can repair permeability defects in the intestine. “Our work could help improve identification of patients who will be better responders to this drug,” said McCole, a...
A new study provides drug developers with clues about how to extend healthy lifespan without severely restricting calorie intake. Research is ongoing into a drug that can mimic the life extending effects of calorie restriction. Scientists have known for some time that restricting calorie intake in laboratory animals can extend their lifespan and reduce their risk...
UT SOUTHWESTERN MEDICAL CENTER IMAGE: ABOVE ARE IMAGES OF A TUMOR IN THE LUNG OF A PATIENT ON ITRACONAZOLE WHO TOOK PART IN THE STUDY, INCLUDING A MAP GENERATED FROM DYNAMIC CONTRAST-ENHANCED (DCE) MAGNETIC RESONANCE. DALLAS – Sept. 17, 2020 – When used to manage infections, the drug itraconazole is generally given at a single,...
In April, Armand Balboni received an anxious call from Tokyo. On the line was a contact from Fujifilm Toyama, the Japanese multinational, who told him that problems were cropping up with a plan to ship 30,000 tablets of the drug known as favipiravir to Canada for a clinical trial. “It was their head of business...
